Mrsa Paper
Methicillin-Resistant Staphylococcus Aureus’s Affects On Pittsburgh’s Communities
Jessie Field
HCS457
Racheline Napier
October 3, 2010 Methicillin-Resistant Staphylococcus Aureus’s Affects On Pittsburgh’s Communities The topic of this paper is Methicillin-Resistant Staphylococcus aureus, better known as MRSA. This is a new disease that has a high resistance to antibiotics. Because of the resistance to most antibiotics, Methicillin-Resistant Staphylococcus Aureus is considered to be a very serious disease.
How long has Methicillin-Resistant Staphylococcus Aureus been a problem? According to the University of Pittsburgh Medical Center, “Methicillin-Resistant Staphylococcus Aureus has been active within the UPMC hospital system since 2001. UPMC also states that they have reduced the infection rates from 1.1 per 1,000 patient days in 2001, to 0.35 per 1,000 patient days in 2009, while saving millions of dollars a year.” (Elixhauser A, Steiner C., July, 2007)
How has Methicillin-Resistant Staphylococcus Aureus affected the community? Methicillin-Resistant Staphylococcus Aureus can have affects on the lungs, skin, lungs, and blood. This disease has two ways of affecting the public. One way is to infect a person; the other is to be inhabited. Methicillin-Resistant Staphylococcus Aureus has two types of infecting the communities. The two types are; community- acquired and nosocomial. The community-acquired type happens outside of a hospital. The nosocomial type takes place within hospitals. Methicillin-Resistant Staphylococcus Aureus can be transmitted by various ways. The ways that Methicillin-Resistant Staphylococcus Aureus is spread is contacted can be by person-to-person, touching an infected area and touching a non-infected area, and dirty surfaces. The highest risk factors in the community-acquired type are; sharing of living spaces, impaired immunity, and having constant skin ailments. In the nosocomial type, the risk factors are; exposure in a
Jessie Field
HCS457
Racheline Napier
October 3, 2010 Methicillin-Resistant Staphylococcus Aureus’s Affects On Pittsburgh’s Communities The topic of this paper is Methicillin-Resistant Staphylococcus aureus, better known as MRSA. This is a new disease that has a high resistance to antibiotics. Because of the resistance to most antibiotics, Methicillin-Resistant Staphylococcus Aureus is considered to be a very serious disease.
How long has Methicillin-Resistant Staphylococcus Aureus been a problem? According to the University of Pittsburgh Medical Center, “Methicillin-Resistant Staphylococcus Aureus has been active within the UPMC hospital system since 2001. UPMC also states that they have reduced the infection rates from 1.1 per 1,000 patient days in 2001, to 0.35 per 1,000 patient days in 2009, while saving millions of dollars a year.” (Elixhauser A, Steiner C., July, 2007)
How has Methicillin-Resistant Staphylococcus Aureus affected the community? Methicillin-Resistant Staphylococcus Aureus can have affects on the lungs, skin, lungs, and blood. This disease has two ways of affecting the public. One way is to infect a person; the other is to be inhabited. Methicillin-Resistant Staphylococcus Aureus has two types of infecting the communities. The two types are; community- acquired and nosocomial. The community-acquired type happens outside of a hospital. The nosocomial type takes place within hospitals. Methicillin-Resistant Staphylococcus Aureus can be transmitted by various ways. The ways that Methicillin-Resistant Staphylococcus Aureus is spread is contacted can be by person-to-person, touching an infected area and touching a non-infected area, and dirty surfaces. The highest risk factors in the community-acquired type are; sharing of living spaces, impaired immunity, and having constant skin ailments. In the nosocomial type, the risk factors are; exposure in a
References: www.cdc.gov/ncidod/hip/ARESIST/mrsa.htm Elixhauser A, Steiner C., Infections with methicillin-resistant Staphylococcus aureus (MRSA) in U.S. Hospitals, 1993-2005, Statistical Brief #35, Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality, July 2007.